Complex Chromosomal Rearrangements by Single Catastrophic Pathogenesis in NUT Midline Carcinoma
Overview
Authors
Affiliations
Background: Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare aggressive malignancy often occurring in the tissues of midline anatomical structures. Except for the pathognomonic BRD3/4-NUT rearrangement, the comprehensive landscape of genomic alterations in NMCs has been unexplored.
Patients And Methods: We investigated three NMC cases, including two newly diagnosed NMC patients in Seoul National University Hospital, and a previously reported cell line (Ty-82). Whole-genome and transcriptome sequencing were carried out for these cases, and findings were validated by multiplex fluorescence in situ hybridization and using individual fluorescence probes.
Results: Here, we present the first integrative analysis of whole-genome sequencing, transcriptome sequencing and cytogenetic characterization of NUT midline carcinomas. By whole-genome sequencing, we identified a remarkably similar pattern of highly complex genomic rearrangements (previously denominated as chromoplexy) involving the BRD3/4-NUT oncogenic rearrangements in two newly diagnosed NMC cases. Transcriptome sequencing revealed that these complex rearrangements were transcribed as very simple BRD3/4-NUT fusion transcripts. In Ty-82 cells, we also identified a complex genomic rearrangement involving the BRD4-NUT rearrangement underlying the simple t(15;19) karyotype. Careful inspections of rearrangement breakpoints indicated that these rearrangements were likely attributable to single catastrophic events. Although the NMC genomes had >3000 somatic point mutations, canonical oncogenes or tumor suppressor genes were rarely affected, indicating that they were largely passenger events. Mutational signature analysis showed predominant molecular clock-like signatures in all three cases (accounting for 54%-75% of all base substitutions), suggesting that NMCs may arise from actively proliferating normal cells.
Conclusion: Taken together, our findings suggest that a single catastrophic event in proliferating normal cells could be sufficient for neoplastic transformation into NMCs.
Li R, Zhang Y, Liu Q, Gao A, Dang Q Medicine (Baltimore). 2025; 103(52):e38881.
PMID: 39969296 PMC: 11688100. DOI: 10.1097/MD.0000000000038881.
Luo J, Bishop J, Dubois S, Hanna G, Sholl L, Stelow E Nat Rev Clin Oncol. 2025; .
PMID: 39900969 DOI: 10.1038/s41571-025-00986-3.
Epigenetics-targeted drugs: current paradigms and future challenges.
Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.
PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma.
Kroening G, Luo J, Evans M, Adeyelu T, Ou S, Arter Z JCO Precis Oncol. 2024; 8:e2400334.
PMID: 39447095 PMC: 11520346. DOI: 10.1200/PO.24.00334.
[NUT cancer of nasal cavity and sinuses: a case report and literature review].
Wang Y, Zhao J, Zhou X, Liu J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(6):530-533.
PMID: 38858120 PMC: 11480580. DOI: 10.13201/j.issn.2096-7993.2024.06.014.